Advertisement

Pharmacy World & Science

, Volume 30, Issue 6, pp 863–868 | Cite as

Analysis and quantification of self-medication patterns of customers in community pharmacies in southern Chile

  • Katherine Fuentes Albarrán
  • Lorenzo Villa ZapataEmail author
Research Article

Abstract

Background Self-medication refers to using drugs which have not been prescribed, recommended or controlled by a licensed health care specialist. Marketing, in Chile only admitted for over-the-counter medications, influences the practice of self-medication and extends it to prescription drugs. Thus, a complex self-medication process is started, due to reuse of a previous prescription, using drugs purchased directly at the pharmacy or drugs coming from family first-aid kits. The purpose of this study is to determine the frequency of self-medication, the type of medications involved, the dosages used, and the reasons for this practice. Methods An observation-based cross-sectional study was carried out at three pharmacies belonging to a pharmacy chain in the city of Valdivia (southern Chile). In addition, a previously validated form was used. Customers who requested over-the-counter medications were surveyed to identify the patterns that foster the self-medication practice. Results Of 909 surveyed customers, 75% self-medicate. Of these, 31% stated that they commonly self-medicate due to suffering from light symptoms, such as headaches (19%), the common cold (8.8%), sore muscles (6.7%), and bone pains (5.3%). The group of medications most requested in this study was nonsteroidal anti-inflammatory drugs (NSAIDs) (33%), with diclofenac sodium being the most used (14%). Influence from other people did not exceed 20% and reusing prior prescriptions reached 46%. There were significant differences when assessing consumer knowledge, reading of information leaflets, and opinions about self-medication at each surveyed pharmacy (P < 0.001). Conclusion Most consumers at the surveyed pharmacies use medications without proper knowledge of their benefits, treatment method, and duration. Drug dispensing at community pharmacies should include active pharmacist involvement to divulge the sensible use of drugs.

Keywords

Chile Community pharmacies Drug utilization Over-the-counter drugs Self-care Self-medication Surveys 

Notes

Acknowledgements

Thanks are extended to the pharmacy chain Salcobrand in the City of Valdivia for allowing us to use their facilities during the research.

Funding

This research was financed by the Pharmacy School of the Facultad de Ciencias of the Universidad Austral de Chile.

Conflicts of interest

There are no conflicts of interest.

References

  1. 1.
    Alfonso GT. El Rol del Farmacéutico en Automedicación. Uso de Medicamentos: análisis desde la Experiencia en España (The Role of the Pharmacist in self-medication. Using Drugs: analysis from the experience in Spain). Pharm Care. 1999;1:157–64.Google Scholar
  2. 2.
    González J. Martín, E. Ruiz, D. Arrebola, M. De la Cruz, P. Ética de la prescripción. Perspectivas desde la atención primaria (Ethics prescription. Perspectives from primary care). Farmacoterapia. 2004;2(4):247–57.Google Scholar
  3. 3.
    Promoción del uso racional de medicamentos: componentes centrales. Perspectivas políticas sobre medicamentos de la OMS. (Rational use of medicines: central components. WHO drugs policies) Ginebra. 2002.Google Scholar
  4. 4.
    Multicenter study on self-medication and self-prescription in six Latin American countries. Drug Utilization Research Group, Latin America. Clin Pharmacol Ther. 1997;61(4):488–93. doi:10.1016/S0009–9236(97)90199-5.Google Scholar
  5. 5.
    Danhier A, Brieva J, Villegas G, Yates T, Perez H, Boggiano G. Use of drugs in an urban population. Rev Med Chil. 1991;119(3):334–7.PubMedGoogle Scholar
  6. 6.
    Hong SH, Spadaro D, West D, Tak SH. Patient valuation of pharmacist services for self care with OTC medications. J Clin Pharm Ther. 2005;30(3):193–9. doi: 10.1111/j.1365-2710.2005.00625.x.PubMedCrossRefGoogle Scholar
  7. 7.
    Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives on over-the-counter (OTC) medicines. Fam Pract. 2005;22(2):170–6. doi: 10.1093/fampra/cmh723.PubMedCrossRefGoogle Scholar
  8. 8.
    Guidelines for the medical assessment of drugs for use in self-medication. World Health Organization (Regional Office for Europe). Copenhagen. 1986.Google Scholar
  9. 9.
    Baos V. Estrategias para Reducir los Riesgos de Automedicación (Strategies to reduce the risk of self-medication). Informacion Ter Sistema Nac Salud Madr. 2000;24:147–52.Google Scholar
  10. 10.
    Sinclair HK, Bond CM, Hannaford PC. Long term follow-up studies of users of nonprescription medicines purchased from community pharmacies: some methodological issues. Drug Saf. 2001;24:929–38. doi: 10.2165/00002018-200124120-00006.PubMedCrossRefGoogle Scholar
  11. 11.
    Nunes de Melo M, Madureira B, Nunes Ferreira AP, Mendes Z, Miranda Ada C, Martins AP. Prevalence of self-medication in rural areas of Portugal. Pharm World Sci. 2006;28(1):19–25. doi: 10.1007/s11096-005-2222-y.PubMedCrossRefGoogle Scholar
  12. 12.
    Bastante T, De la Morena F. Automedicación en Población Universitaria, Universidades Autónoma, Complutense y Carlos III de Madrid, España. [Self-medication in the University population] Madrid. 2000.Google Scholar
  13. 13.
    Tobon F. Estudio sobre automedicación en la Universidad de Antioquía (Study about self-medication at the University of Antioquía), Medellín, Colombia. IATREIA. 2002;15(4):242–7.Google Scholar
  14. 14.
    Smalley WE, Griffin MR. The risks and costs of upper gastrointestinal disease attributable to NSAIDs. Gastroenterol Clin North Am. 1996;25:373–96. doi: 10.1016/S0889-8553(05)70253-3.PubMedCrossRefGoogle Scholar
  15. 15.
    Wolfe M, Lichtenstein D, Singh G. Medical progress: gastrointestinal toxicity of nonsteroidal antiinflamatory drugs. N Engl J Med. 1999;340:1888–99. doi: 10.1056/NEJM199906173402407.PubMedCrossRefGoogle Scholar
  16. 16.
    Singh G, Ramey DR. NSAID-induced gastrointestinal complications: the ARAMIS perspective-1997. J Rheumatol. 1998;25(suppl 51):8–16.Google Scholar
  17. 17.
    Richy F, Bruyere O, Ethgen O, Rabenda V, Bouvenot G, Audran M, et al. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis. 2004;63:759–66. doi: 10.1136/ard.2003.015925.PubMedCrossRefGoogle Scholar
  18. 18.
    Laporte JR. Automedicación: ¿la información de los usuarios aumenta al mismo tiempo que el consumo? (Self-medication: is the user information increasing consumption?) Med Clin (Barc). 1997;109:795–6.Google Scholar
  19. 19.
    Vanin JR, Saylor KE. Laxative abuse: a hazardous habit for weight control. Coll Health. 1989;37:227–30.Google Scholar
  20. 20.
    Fleming GF, McElnay JC, Hughes CM. Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: a pilot study. Pharm World Sci. 2004;26(5):282–8. doi:10.1023/B:PHAR.0000042891.66983.60.
  21. 21.
    Edmeads JG, Gawel MJ, Vickers J. Strategies for diagnosing and managing medication-induced headache. Can Fam Physician. 1997;43:1249–54.PubMedGoogle Scholar
  22. 22.
    Riedemann J, Illesca M, Droghetti J. Automedicación en individuos de la Región de la Araucanía con problemas musculoesqueléticos (Self medication among patients with musculoskeletal symptoms), Chile. Rev Med Chil. 2001;129:647–52.Google Scholar
  23. 23.
    Huber W. Uso racional de medicamentos: encuesta a directores técnicos de farmacias de la Región Metropolitana, V Región, (Rational use of drugs: survey to pharmacy directors of the Metropolitan Region) Zona Norte y Zona Sur de Chile. Pharmakon. 2005;9:11–4.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Katherine Fuentes Albarrán
    • 1
  • Lorenzo Villa Zapata
    • 1
    Email author
  1. 1.Instituto de Farmacia, Facultad de CienciasUniversidad Austral de ChileValdiviaChile

Personalised recommendations